Results for tag: "Simeprevir"

Simeprevir is a medication used to treat chronic hepatitis C virus (HCV) infection. It is a protease inhibitor, which works by blocking the action of the HCV protease enzyme, preventing the virus from replicating. Simeprevir is usually used in combination with other antiviral medications, such as sofosbuvir or peginterferon alfa. It is approved for use in adults with genotype 1, 4, 5, or 6 HCV infection. Simeprevir is available in capsule form and is taken orally once daily. Common side effects include nausea, headache, and fatigue. Serious side effects include liver damage, anemia, and allergic reactions. The simeprevir market is a subset of the larger infectious diseases drugs market. It is a rapidly growing market, driven by the increasing prevalence of HCV infection and the development of new treatments. The market is highly competitive, with several major players offering simeprevir-based treatments. Some companies in the simeprevir market include Janssen Pharmaceuticals, Gilead Sciences, and Merck & Co. Show Less Read more